help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 18, 2008, doi:10.1164/rccm.200804-592OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow Editorial: Farrah Kheradmand, Amarbir Singh Mattewal, David B. Corry
Right arrow All Versions of this Article:
200804-592OCv1
179/5/344    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gereke, M.
Right arrow Articles by Bruder, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gereke, M.
Right arrow Articles by Bruder, D.
American Journal of Respiratory and Critical Care Medicine Vol 179. pp. 344-355, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200804-592OC


Original Article

Alveolar Type II Epithelial Cells Present Antigen to CD4+ T Cells and Induce Foxp3+ Regulatory T Cells

Marcus Gereke1, Steffen Jung2, Jan Buer3 and Dunja Bruder1

1 Immune Regulation Group, Helmholtz Centre for Infection Research, Braunschweig, Germany; 2 Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; and 3 Department of Medical Microbiology, University Hospital Essen, Essen, Germany

Correspondence and requests for reprints should be addressed to Dunja Bruder, Ph.D., Immune Regulation Group, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany. E-mail: dunja.bruder{at}helmholtz-hzi.de

Rationale: Although the contribution of alveolar type II epithelial cells (AECIIs) in respiratory immunity has become increasingly appreciated, their precise function in the induction and regulation of T-cell reactivity to self-antigen remains poorly understood.

Objectives: To investigate the role of AECII in the initiation of T-cell reactivity to alveolar self-antigen, and to clarify their function in the peripheral induction of Foxp3+ regulatory CD4+ T cells.

Methods: To dissect the complex cellular and molecular functions of AECIIs in lung inflammation and immune regulation, we use a transgenic mouse model for CD4+ T-cell–mediated pulmonary inflammation.

Measurements and Main Results: Here we report that AECIIs present endogenously expressed antigen on major histocompatibility complex class II molecules to CD4+ T cells. Epithelial antigen display was sufficient to induce primary T-cell activation and pulmonary inflammation. Upon inflammation, AECIIs induce the differentiation of Foxp3+ regulatory T cells by a mechanism involving antiproliferative soluble factors, including transforming growth factor (TGF)-β. Whereas, in acute inflammation, TGF-β appears to be the dominant factor to induce regulatory T cells, other AECII-derived factors can substitute for and/or synergize with TGF-β in chronic pulmonary inflammations.

Conclusions: AECIIs are capable of priming naive CD4+ T cells, demonstrating an active participation of these cells in respiratory immunity. Moreover, AECIIs display as yet unrecognized functions in balancing inflammatory and regulatory T-cell responses in the lung by connecting innate and adaptive immune mechanisms to establish peripheral T-cell tolerance to respiratory self-antigen.

Key Words: peripheral tolerance • alveolar type II epithelial cells • immune regulation • autoimmunity • transgenic mouse model


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
The contribution of type II alveolar epithelial cells (AECIIs) to respiratory immune regulation has become increasingly appreciated. However, their precise function in the induction and regulation of T-cell reactivity to self-antigens remains poorly understood.

What This Study Adds to the Field
We show here that major histocompatibility complex class II–expressing AECIIs present self-antigen to CD4+ T cells, resulting in functional activation of lung-reactive T cells. However, AECIIs also induce Foxp3+ regulatory T cells, thereby promoting lung tolerance.

 

Related articles in AJRCCM:

At Last, an Immune Organ We Can Call Our Own?
Farrah Kheradmand, Amarbir Singh Mattewal, and David B. Corry
AJRCCM 2009 179: 525-527. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
R. H. Wilson, G. S. Whitehead, H. Nakano, M. E. Free, J. K. Kolls, and D. N. Cook
Allergic Sensitization through the Airway Primes Th17-dependent Neutrophilia and Airway Hyperresponsiveness
Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 720 - 730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Kheradmand, A. S. Mattewal, and D. B. Corry
At Last, an Immune Organ We Can Call Our Own?
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 525 - 527.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  Subscribe to PATS